Patents by Inventor Motonari Uesugi

Motonari Uesugi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20130005768
    Abstract: The present invention relates to treatment and/or prevention of one or more metabolic disorders utilizing fatostatin A and/or a derivative and/or analog thereof. In other aspects, the compound for treatment and/or prevention of one or more metabolic disorders utilizes an A-B-C tripartite structure, wherein A, B, and C are identical or non-identical structures and are described in detail herein. In specific aspects, the metabolic disorder includes obesity or diabetes, for example.
    Type: Application
    Filed: May 31, 2012
    Publication date: January 3, 2013
    Applicant: Baylor College of Medicine
    Inventors: Motonari Uesugi, Salih J. Wakil, Lutfi Abu-Elheiga, Qian Mao, Shinji Kamisuki, Akira Kugimiya
  • COMPOSITION FOR PROMOTING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO CARDIAC MUSCLE CELLS WHICH COMPRISES NITROVIN
    Publication number: 20120244619
    Abstract: The present invention provides a composition for promoting differentiation of pluripotent stem cells into cardiac muscle cells which comprises nitrovin, a method for inducing differentiation of pluripotent stem cells into cardiac muscle cells by using nitrovin and a method for preparing cardiac muscle cells by using nitrovin.
    Type: Application
    Filed: December 9, 2010
    Publication date: September 27, 2012
    Applicant: KYOTO UNIVERSITY
    Inventors: Norio Nakatsuji, Motonari Uesugi, Itsunari Minami, Tomomi Otsuji
  • Compositions and methods for the treatment of metabolic disorders
    Patent number: 8207196
    Abstract: The present invention relates to treatment and/or prevention of one or more metabolic disorders utilizing fatostatin A and/or a derivative and/or analog thereof. In other aspects, the compound for treatment and/or prevention of one or more metabolic disorders utilizes an A-B-C tripartite structure, wherein A, B, and C are identical or non-identical structures and are described in detail herein. In specific aspects, the metabolic disorder includes obesity or diabetes, for example.
    Type: Grant
    Filed: February 1, 2008
    Date of Patent: June 26, 2012
    Assignee: Baylor College of Medicine
    Inventors: Motonari Uesugi, Salih J. Wakil, Lutfi Abu-Elheiga, Qian Mao, Shinji Kamisuki, Akira Kugimiya
  • CELL ADHESION PROMOTING AGENT AND METHOD OF PROMOTING CELL ADHESION
    Publication number: 20110117651
    Abstract: The subject invention discloses an agent for promoting cell adhesion to a support, comprising a dispirotripiperazine derivative represented by Formula I below or a salt thereof; a method for promoting cell adhesion to a support comprising adding the dispirotripiperazine derivative represented by Formula I below or a salt thereof to a culture medium, or applying the same to a support; and an agonist of a heparin sulfate that comprises the dispirotripiperazine derivative represented by Formula I below or a salt thereof, and that promotes cell adhesion and/or cell growth.
    Type: Application
    Filed: June 16, 2009
    Publication date: May 19, 2011
    Inventors: Motonari Uesugi, Sayumi Yamazoe
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF METABOLIC DISORDERS
    Publication number: 20090131475
    Abstract: The present invention relates to treatment and/or prevention of one or more metabolic disorders utilizing fatostatin A and/or a derivative and/or analog thereof. In other aspects, the compound for treatment and/or prevention of one or more metabolic disorders utilizes an A-B—C tripartite structure, wherein A, B, and C are identical or non-identical structures and are described in detail herein. In specific aspects, the metabolic disorder includes obesity or diabetes, for example.
    Type: Application
    Filed: February 1, 2008
    Publication date: May 21, 2009
    Applicant: Baylor College of Medicine
    Inventors: Motonari Uesugi, Salih J. Wakil, Lutfi Abu-Elheiga, Qian Mao, Shinji Kamisuki, Akira Kugimiya
  • Small molecule inhibitors of HER2 expression
    Patent number: 7449480
    Abstract: Peptide mimetic small molecule inhibitors of Sur-2 are provided having the general formula:
    Type: Grant
    Filed: February 2, 2004
    Date of Patent: November 11, 2008
    Assignee: Baylor College of Medicine
    Inventors: Motonari Uesugi, Shinichi Asada
  • Small molecule inhibitors of HER2 expression
    Patent number: 7019017
    Abstract: Peptide mimetic small molecule inhibitors of Sur-2 are provided having the general formula:
    Type: Grant
    Filed: April 2, 2003
    Date of Patent: March 28, 2006
    Assignee: Baylor College of Medicine
    Inventors: Motonari Uesugi, Shinichi Asada
  • Small molecule inhibitors of HER2 expression
    Publication number: 20050288327
    Abstract: Peptide mimetic small molecule inhibitors of Sur-2 are provided having the general formula:
    Type: Application
    Filed: July 20, 2005
    Publication date: December 29, 2005
    Inventors: Motonari Uesugi, Shinichi Asada
  • Small molecule inhibitors of HER2 expression
    Publication number: 20050283007
    Abstract: Peptide mimetic small molecule inhibitors of Sur-2 are provided having the general formula:
    Type: Application
    Filed: February 2, 2004
    Publication date: December 22, 2005
    Inventors: Motonari Uesugi, Shinichi Asada
  • Small molecule inhibitors of HER2 expression
    Publication number: 20040006106
    Abstract: Peptide mimetic small molecule inhibitors of Sur-2 are provided having the general formula: 1
    Type: Application
    Filed: April 2, 2003
    Publication date: January 8, 2004
    Applicant: Baylor College of Medicine
    Inventors: Motonari Uesugi, Shinichi Asada